SCHEMBL8568100

SCHEMBL8568100

Cc1cc(Cl)cc2[nH]c(=O)oc(=O)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.46
NOS2 P35228 3/20 0.46
NOS3 P29474 2/20 0.46
LMNA P02545 2/20 0.46
CYP1A2 P05177 2/20 0.46
TSHR P16473 2/20 0.46
BLM P54132 2/20 0.46
ADRA2A P08913 1/20 0.46
THPO P40225 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KMO O15229 1/20 0.41
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
F2 P00734 1/20 0.37
CFD P00746 1/20 0.37
PDGFRA P16234 1/20 0.37
MAPK8 P45983 1/20 0.37
CDK5 Q00535 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
NOTUM Q6P988 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8573976 0.82 CYP1A2 (0.49) NOS1NOS2NOS3LMNACYP1A2
SCHEMBL8570180 0.82 NOS1 (0.49) NOS1NOS2NOS3F2CFD
SCHEMBL11301720 0.80 NOS1 (0.50) NOS1NOS2NOS3LMNACYP1A2
SCHEMBL19243874 0.79 NOS1 (0.39) NOS1NOS2NOS3KMOF2
SCHEMBL27474482 0.79 AR (0.42) NOS1NOS2NOS3KMOF2
SCHEMBL8572742 0.76 NOS1 (0.46) NOS1NOS2NOS3LMNACYP1A2
SCHEMBL634152 0.72 LMNA (0.38) NOS1NOS2NOS3LMNACYP1A2
SCHEMBL30087001 0.72 LMNA (0.38) NOS1NOS2NOS3LMNACYP1A2
SCHEMBL619937 0.71 F2 (0.52) NOS1NOS2NOS3CYP1A2F2
SCHEMBL10732234 0.71 CYP1A2 (0.52) NOS1NOS2NOS3LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5739133-A N-ACYLATED AND ALKYLATED DERIVATIVES OF PYRIDAZINO(4,5-B)-QUINOLINES; EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS; STROKES; ANTIISCHEMIC AND HYPOGLYCEMIC AGENTS; PSYCHOSIS; NEUROGODEGENERATIVE DISORDERS ZENECA LIMITED (GB) 1998-04-14 US disclosed
US-5733910-A Pyridazinedione compounds useful in the treating neurological disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1998-03-31 US disclosed
US-5604227-A EXCITATORY AMINO ACID ANTAGONIST; MONO, DI OR TRI-ACETYLATION OR ALKYLATION IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1997-02-18 US disclosed
US-5599814-A SUBSTITUTED PYRIDAZINO(4,5-B)QUINOLINES AS ANTAGONISTS OF EXCITATORY AMINO ACIDS IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1997-02-04 US disclosed
EP-0516297-B1 Pyridazinediones and their use in the treatment of neurological disorders ZENECA LTD (GB) 1996-10-30 EP disclosed
EP-0516297-A1 Pyridazinediones and their use in the treatment of neurological disorders ZENECA LIMITED (GB) 1992-12-02 EP disclosed